Sort by
Search results
ZYMUTEST Protein S Total
Diagnosis of protein S deficiencies (congenital, acquired or transitory) • Type I deficiency: Partial deficiency of total and free protein S antigen • Type II deficiency: Normal total and free protein S antigen, reduced activity • Type III deficiency: Normal total antigen, decreased activity and free antigen, assay of protein S in clinical studies.
ZYMUTEST Protein C Antigen
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
ZYMUTEST PF4 Antigen
Assay proposed for the measurement of platelet factor 4 in research application.
ZYMUTEST PAI-1 Antigen
Assay of PAI-1: Ag in clinical samples. Measurement of PAI-1 as a cardiovascular risk factor. Assay of PAI-1 in diabetes or in metabolic disorders.
ZYMUTEST PAI-1 Activity
Assay proposed for the measurement of PAI-1 activity in research applications.
ZYMUTEST HIA, IgGAM Screening
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT. Clinical suspicion of HIT during heparin therapy.
ZYMUTEST HIA, IgG
Clinical suspicion of HIT during heparin therapy Clinical suspicion of vaccine-induced immune thrombotic thrombocytopenia (VITT) Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
ZYMUTEST HIA Mono-Strip, IgG
Individual test. Clinical suspicion of HIT during heparin therapy. Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA Mono Strip IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
ZYMUTEST Free Protein S
Diagnosis of protein S deficiencies (congenital, acquired or transitory). • Type I deficiency: Partial deficiency of total and free protein S antigen. • Type II deficiency: Normal total and free protein S antigen, reduced activity. • Type III deficiency: Normal total antigen, decreased activity and free antigen. Assay of protein S in clinical studies.
ZYMUTEST Fibrinogen Antigen
Assay proposed for the measurement of fibrinogen in research applications.